[go: up one dir, main page]

DE69618634D1 - 1,4-benzodioxin-derivate - Google Patents

1,4-benzodioxin-derivate

Info

Publication number
DE69618634D1
DE69618634D1 DE69618634T DE69618634T DE69618634D1 DE 69618634 D1 DE69618634 D1 DE 69618634D1 DE 69618634 T DE69618634 T DE 69618634T DE 69618634 T DE69618634 T DE 69618634T DE 69618634 D1 DE69618634 D1 DE 69618634D1
Authority
DE
Germany
Prior art keywords
benzodioxin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69618634T
Other languages
English (en)
Other versions
DE69618634T2 (de
Inventor
Toshihiro Takahashi
Kohei Inomata
Norio Oshida
Nobutoshi Kubota
Tamiko Hamada
Naohito Iwata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Pharma Inc
Original Assignee
Nisshin Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Pharma Inc filed Critical Nisshin Pharma Inc
Application granted granted Critical
Publication of DE69618634D1 publication Critical patent/DE69618634D1/de
Publication of DE69618634T2 publication Critical patent/DE69618634T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69618634T 1995-05-12 1996-05-13 1,4-benzodioxin-derivate Expired - Fee Related DE69618634T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13744095 1995-05-12
PCT/JP1996/001252 WO1996035685A1 (en) 1995-05-12 1996-05-13 1,4-benzodioxin derivatives

Publications (2)

Publication Number Publication Date
DE69618634D1 true DE69618634D1 (de) 2002-02-28
DE69618634T2 DE69618634T2 (de) 2002-06-20

Family

ID=15198681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618634T Expired - Fee Related DE69618634T2 (de) 1995-05-12 1996-05-13 1,4-benzodioxin-derivate

Country Status (8)

Country Link
US (1) US6130243A (de)
EP (1) EP0825189B1 (de)
JP (1) JP3068198B2 (de)
KR (1) KR100490003B1 (de)
CA (1) CA2220759C (de)
DE (1) DE69618634T2 (de)
ES (1) ES2170855T3 (de)
WO (1) WO1996035685A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632955B1 (en) 1996-12-02 2003-10-14 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
US5965607A (en) * 1996-12-30 1999-10-12 American Home Products Corporation Substituted Benzo[1,4]dioxines as antiobesity agents
AU5723098A (en) * 1996-12-30 1998-07-31 American Home Products Corporation Substituted benzo{1,4}dioxanes as antiobesity agents
DE69938645D1 (de) 1998-07-31 2008-06-19 Nisshin Pharma Inc Optisch aktive 1,4-benzodioxin-2-carbonsäure-derivate und verfahren zu ihrer herstellung
JP2002053574A (ja) 2000-08-10 2002-02-19 Nisshin Pharma Inc １，４−ベンゾジオキサン環を有するプロパノールアミン誘導体
EP1426370A4 (de) * 2001-09-13 2009-12-23 Nisshin Pharma Inc Propanolaminderivat mit 1,4-benzodioxanring
JP4094937B2 (ja) 2001-11-19 2008-06-04 三星電子株式会社 モニタ装置
CA2480410A1 (en) * 2002-04-10 2003-10-23 Esperion Therapeutics, Inc. Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
KR100520060B1 (ko) 2002-05-28 2005-10-11 삼성전자주식회사 모니터장치
AU2003241747A1 (en) * 2002-06-11 2003-12-22 Kaneka Corporation PROCESS FOR PRODUCING OPTICALLY ACTIVE ss-AMINO ALCOHOL
KR100465792B1 (ko) 2002-07-06 2005-01-13 삼성전자주식회사 디스플레이장치
KR100630969B1 (ko) 2002-08-24 2006-10-02 삼성전자주식회사 디스플레이장치
KR100476090B1 (ko) 2002-09-27 2005-03-11 삼성전자주식회사 모니터장치
KR100482007B1 (ko) 2002-09-28 2005-04-13 삼성전자주식회사 모니터장치
KR100770981B1 (ko) 2002-10-30 2007-10-30 삼성전자주식회사 디스플레이의 스탠드
KR100500234B1 (ko) 2002-11-05 2005-07-11 삼성전자주식회사 디스플레이장치
KR100826605B1 (ko) 2002-11-11 2008-04-30 삼성전자주식회사 모니터장치
WO2004070045A1 (ja) * 2003-02-10 2004-08-19 Nisshin Pharma Inc. 光学活性な６－ホルミル－１,４－ベンゾジオキシン－２－カルボン酸誘導体の製造方法
KR100770984B1 (ko) 2003-05-23 2007-10-30 삼성전자주식회사 디스플레이 장치
WO2005083102A1 (ja) * 2004-03-01 2005-09-09 Mercian Corporation 光学活性1,4-ベンゾジオキシン-2-カルボン酸誘導体の製造方法
TW200740779A (en) * 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
WO2007139062A1 (ja) * 2006-05-30 2007-12-06 Kyorin Pharmaceutical Co., Ltd. 肥満治療剤並びに肥満の治療及び予防方法
WO2007145203A1 (ja) * 2006-06-13 2007-12-21 Daiichi Fine Chemical Co., Ltd. 光学活性２－アミノ－１－（４－フルオロフェニル）エタノール
US10052326B1 (en) 2017-10-12 2018-08-21 King Saud University Antihepatotoxic agents
WO2024124353A1 (en) * 2022-12-16 2024-06-20 Enveric Biosciences Canada Inc. Substituted ethylamine fused heterocyclic mescaline derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205079A (en) * 1978-10-16 1980-05-27 Shell Oil Company Benzodioxincarboxamides
ATE1994T1 (de) * 1979-06-16 1982-12-15 Beecham Group Plc Aethanamin-derivate, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
ATE163930T1 (de) * 1993-01-29 1998-03-15 American Cyanamid Co Aminocycloalkanobenzodioxole als beta-3 selektive adrenergische wirkstoffe
JPH06293664A (ja) * 1993-04-05 1994-10-21 Fujisawa Pharmaceut Co Ltd β３−アドレナリン作動薬の新規医薬用途
US5482971A (en) * 1993-10-01 1996-01-09 American Cyanamid Company Beta3 -adrenergic agents and their use in pharmaceutical compositions
JPH07228543A (ja) * 1994-02-16 1995-08-29 Fujisawa Pharmaceut Co Ltd β３−アドレナリン作動薬の新規医薬用途

Also Published As

Publication number Publication date
CA2220759A1 (en) 1996-11-14
JP3068198B2 (ja) 2000-07-24
EP0825189A4 (de) 1998-08-05
US6130243A (en) 2000-10-10
DE69618634T2 (de) 2002-06-20
ES2170855T3 (es) 2002-08-16
EP0825189A1 (de) 1998-02-25
KR100490003B1 (ko) 2005-12-21
EP0825189B1 (de) 2002-01-02
CA2220759C (en) 2009-01-20
WO1996035685A1 (en) 1996-11-14
KR19990014740A (ko) 1999-02-25

Similar Documents

Publication Publication Date Title
DE69636353D1 (de) Datenübetragungsvorrichtung.
NL1004863A1 (nl) 5-Amino-4-ethylsulfinyl-1-arylpyrazolen.
MA23780A1 (fr) Quinazolinones 2, 8 disubstitues
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
DK0771789T3 (da) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
DE69618634D1 (de) 1,4-benzodioxin-derivate
NO960223D0 (no) 2,9-disubstituerte purin-6-oner
BR9506532A (pt) 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
NL1000095C2 (nl) Rolhor.
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
EP0811014A4 (de) Neuartiges bakteriozin, piscicolin 126
NO960353L (no) 4-aminobenzoylguanidinderivater
NO960392L (no) 4-merkaptobenzoylguanidinderivater
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
ES1032571Y (es) Gafa,
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
ITMI941593A1 (it) Tetraidropiridine 3, 3-disostituite
FI952416A0 (fi) Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor
FI950956A0 (fi) Luftkabel, saosom haengspiralkabel
ES1030500Y (es) Braga-compresa monouso.
ES1030262Y (es) Porta-objetos.
IT239292Y1 (it) Volter.
IT240242Y1 (it) Pentola-colapasta-zuppiera.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee